Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol Vaginal Inserts for Dyspareunia in Women With Vulvar and Vaginal Atrophy
NCT05617820Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2022
- Primary completion
- Mar 2024
- Modality
- Hormone, Biologic
- Countries
- 3
01
Overview
A Phase 3 trial of estradiol vaginal cream in dyspareunia, sponsored by Teva Pharmaceutical Industries Ltd.. Started Nov 2022; status: completed.
02
Drugs
estradiol vaginal cream
03
Conditions
dyspareunia
Beyond the preview
Go deeper on NCT05617820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05617820.